NOW AVAILABLE 1
A variant-adapted monovalent COVID-19 vaccine 1
COMIRNATY Omicron XBB . 1.5 has been updated to match circulating SARS-CoV-2 strains to help reduce the risk of severe disease . 1 – 3
ATAGI advises monovalent Omicron XBB . 1.5 as the preferred COVID-19 vaccine for : 2
• Children 5 years and older
• Adults who are recommended to receive primary or additional COVID-19 vaccine doses *
* As per the Australian Immunisation Handbook .
Scan the QR code to view the full recommendations .
For more information on COMIRNATY and other useful resources , scan the QR code or visit pfizerpro . au
A one-time sign-up is required , which will provide you with access to Pfizer ’ s range of digital services .
Help protect your patients with COMIRNATY ® Omicron XBB . 1.5 COVID-19 vaccine 1
References : 1 . COMIRNATY ® Omicron XBB . 1.5 ( raxtozinameran ) COVID-19 VACCINE Product Information . 2 . Australian Technical Advisory Group on Immunisation ( ATAGI ). Clinical Advice : Statement on the Administration of COVID-19 Vaccines in 2024 , 29 February 2024 . Available at : https :// www . health . gov . au / sites / default / files / 2024-03 / atagi-statement-on-the-administration-of-covid-19-vaccines-in-2024 . pdf . Accessed 4 March 2024 . 3 . World Health Organization . Statement on the antigen composition of COVID-19 vaccines . Updated May 18 , 2023 . Available at : www . who . int / news / item / 18-05-2023-statement-on-the-antigen-composition-ofcovid-19-vaccines . Accessed 15 February 2024 .
Before prescribing , please review the Approved Product Information available by scanning the QR code , visiting www . pfizer . com . au or calling 1800 675 229 .
▼ This vaccine is subject to additional monitoring in Australia . This will allow quick identification of new safety information . Healthcare professionals are asked to report any suspected adverse events at : www . tga . gov . au / reporting-problems .
PBS Information : This product is not listed on the PBS or the NIP .
COMIRNATY ® is a registered trademark of BioNTech SE , used under license . © 2024 Pfizer Australia Pty Ltd . Sydney , Australia . All rights reserved . Pfizer Medical Information : 1800 675 229 . COM-002564-00 . PP-CMR-AUS-0310 . 03 / 24 .